A Study of OV101 in Individuals With Fragile X Syndrome
NCT03697161
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Fragile X Syndrome (FXS)
Interventions
DRUG:
OV101 (gaboxadol)
Sponsor
Healx AI